4
Changes in Ownership
Celldex Therapeutics, Inc. Filed Acc 0001960596-25-000008
Options or other derivatives
- SVP & Chief Commercial Officer acquired 100,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lawver Teri L SVP & Chief Commercial Officer | 2025-11-10 | Grant or award · ISO (right to buy) | +100,000 | 100,000 | D | ||
Loading xslF345X05/form4-11122025_091122.xml…